Vertex Pharmaceuticals Incorporated is a Strong Buy with cystic fibrosis dominance, a diversified pipeline, and growth ...

Vertex Pharmaceuticals is cranking up the charm on Wall Street with a whopping $4 billion share buyback plan, signaling ...

The stock's fall snapped a four-day winning streak.

With a market cap of $114.8 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company specializing in ...

Vertex Pharmaceuticals VRTX +1.22% Get Free Report has outperformed the market over the past 20 years by 10.58% on an ...

Intermede Investment Partners just dropped a cool $98.9 million into VRTX stock, sparking Wall Street’s interest in biotech ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.68% to $432.00 Tuesday, on what proved to be an all-around mixed trading ...

Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 15 years ago, it would be worth $11,812.35 today based on ...

Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was ...

Two excellent candidates are Vertex Pharmaceuticals ( VRTX -1.05%) and Axsome Therapeutics ( AXSM -1.06%). Here's what makes ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...